Bio-Rad Laboratories (NYSE:BIO.B) Issues Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B) released its quarterly earnings data on Thursday. The company reported $3.11 earnings per share for the quarter, Zacks reports. Bio-Rad Laboratories had a negative net margin of 51.73% and a positive return on equity of 3.56%. The company had revenue of $638.48 million for the quarter.

Bio-Rad Laboratories Stock Performance

BIO.B stock traded up $32.55 during trading hours on Friday, hitting $326.78. 119 shares of the stock were exchanged, compared to its average volume of 26. Bio-Rad Laboratories has a 12 month low of $271.00 and a 12 month high of $373.78. The company has a current ratio of 6.57, a quick ratio of 4.89 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $9.32 billion, a P/E ratio of -31.54 and a beta of 0.72. The company has a 50-day simple moving average of $286.51 and a two-hundred day simple moving average of $305.51.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.